ZA952418B - Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administration - Google Patents

Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administration

Info

Publication number
ZA952418B
ZA952418B ZA952418A ZA952418A ZA952418B ZA 952418 B ZA952418 B ZA 952418B ZA 952418 A ZA952418 A ZA 952418A ZA 952418 A ZA952418 A ZA 952418A ZA 952418 B ZA952418 B ZA 952418B
Authority
ZA
South Africa
Prior art keywords
trimetazidine
pharmaceutical compositions
oral administration
prolonged release
compositions permitting
Prior art date
Application number
ZA952418A
Inventor
Bruno Huet De Barochez
Patrick Genty
Alain Cuine
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA952418B publication Critical patent/ZA952418B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Compsn. for prolonged liberation of trimetazidine (II) or its salts, uses a polymer insoluble in water and a plasticiser to control liberation.
ZA952418A 1994-03-24 1995-03-24 Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administration ZA952418B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9403434A FR2717687B1 (en) 1994-03-24 1994-03-24 Pharmaceutical compositions for the sustained release of trimetazidine after oral administration.

Publications (1)

Publication Number Publication Date
ZA952418B true ZA952418B (en) 1995-12-18

Family

ID=9461361

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952418A ZA952418B (en) 1994-03-24 1995-03-24 Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administration

Country Status (15)

Country Link
EP (1) EP0673649B1 (en)
JP (1) JP3017040B2 (en)
CN (1) CN1056057C (en)
AT (1) ATE216583T1 (en)
AU (1) AU684893B2 (en)
CA (1) CA2145248C (en)
DE (1) DE69526467T2 (en)
DK (1) DK0673649T3 (en)
ES (1) ES2176296T3 (en)
FI (1) FI116881B (en)
FR (1) FR2717687B1 (en)
NO (1) NO306450B1 (en)
NZ (1) NZ270791A (en)
PT (1) PT673649E (en)
ZA (1) ZA952418B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802424B1 (en) * 1999-12-17 2002-02-15 Adir MATRIX TABLET FOR THE EXTENDED RELEASE OF TRIMETAZIDINE AFTER ORAL ADMINISTRATION
ATE442852T1 (en) * 2000-10-05 2009-10-15 Usv Ltd DELAYED-RELEASE MEDICINAL COMPRISING TRIMETAZIDINE AND METHOD FOR THE PRODUCTION
FR2818549B1 (en) * 2000-12-26 2003-02-07 Servier Lab SOLID THERMOFORMABLE PHARMACEUTICAL COMPOSITION FOR THE CONTROLLED RELEASE OF TRIMETAZIDINE
AU2002356425A1 (en) * 2001-11-21 2003-06-10 Themis Laboratories Private Limited A process for manufacture of a sustained release composition containing microbe
FR2885807B1 (en) * 2005-05-18 2008-05-16 Mg Pharma SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD
WO2007116243A2 (en) * 2006-04-10 2007-10-18 Mintails Limited Method for treating fibromyalgia and related conditions
EP2200591A2 (en) 2007-09-11 2010-06-30 Ranbaxy Laboratories Limited Controlled release pharmaceutical dosage forms of trimetazidine
JP2012515757A (en) 2009-01-20 2012-07-12 マイクロ ラブス リミテッド Trimetazidine controlled release solid pharmaceutical composition and method for producing the same
PL2391353T3 (en) * 2009-01-30 2016-09-30 Pharmaceutical compositions of trimetazidine
TR201001902A2 (en) 2010-03-12 2011-04-21 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Trimetazidine tablets with extended release
US20110274751A1 (en) 2010-05-04 2011-11-10 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Trimetazidine formulation with different release profiles
EP2386302A1 (en) 2010-05-11 2011-11-16 Ranbaxy Laboratories Limited A controlled release pharmaceutical dosage form of trimetazidine and processes for the preparation thereof
BG1345U1 (en) * 2010-05-20 2010-08-31 "Адифарм" Ад Modified-release pharmaceutical formulation
EP2491930A1 (en) 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Pharmaceutical combination of betahistine and trimetazidine
CN102133195A (en) * 2011-03-17 2011-07-27 王国栋 Trimetazidine dihydrochloride sustained control release pellet and preparation method thereof
CN102319225B (en) * 2011-09-23 2013-04-03 广州白云山光华制药股份有限公司 Trimetazidine hydrochloride sustained release tablet and preparation method thereof
FR2986431B1 (en) 2012-02-03 2017-03-17 Servier Lab PROLONGED RELEASE OF TRIMETAZIDINE PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PRODUCTION THEREOF AND USE IN THERAPEUTIC TREATMENTS
CN102764261A (en) * 2012-07-30 2012-11-07 沈阳药科大学 Oral composition controlling release of trimetazidine dihydrochloride and preparation method of oral composition
CN103565751A (en) * 2013-10-17 2014-02-12 广州帝奇医药技术有限公司 Long-acting sustained-release pellet and preparation method thereof
US20190381034A1 (en) * 2018-06-14 2019-12-19 Ming Fang Pharmaceutical composition and method for acute on chronic liver failure and related liver diseases
CN110237053A (en) * 2019-07-26 2019-09-17 湖北欣泽霏药业有限公司 A kind of trimetazidine hydrochloride sustained-release pellet and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490963B1 (en) * 1980-09-30 1986-04-18 Science Union & Cie NOVEL THERAPEUTIC COMPOSITION WITH ANTI-ISCHEMIC ACTION CONTAINING TRIMETHOXY 2, 3, 4-BENZYL 1-PIPERAZINE
DE3686275T2 (en) * 1985-01-11 1993-03-18 Teijin Ltd PREPARED PRODUCTS WITH DELAYED RELEASE.
JPH0625055B2 (en) * 1985-03-18 1994-04-06 日本ケミフア株式会社 Persistent tablets
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
US5417983A (en) * 1992-02-19 1995-05-23 Sagami Chemical Research Center Drug release controlling material responsive to changes in temperature

Also Published As

Publication number Publication date
NZ270791A (en) 1996-07-26
EP0673649A1 (en) 1995-09-27
CN1056057C (en) 2000-09-06
ATE216583T1 (en) 2002-05-15
CA2145248A1 (en) 1995-09-25
NO306450B1 (en) 1999-11-08
AU684893B2 (en) 1998-01-08
JPH07258086A (en) 1995-10-09
EP0673649B1 (en) 2002-04-24
PT673649E (en) 2002-08-30
FR2717687B1 (en) 1996-06-14
CN1124140A (en) 1996-06-12
FI116881B (en) 2006-03-31
DE69526467T2 (en) 2002-12-05
NO951110L (en) 1995-09-25
JP3017040B2 (en) 2000-03-06
DK0673649T3 (en) 2002-08-05
FI951357A (en) 1995-09-25
CA2145248C (en) 2004-01-06
AU1502995A (en) 1995-10-05
FR2717687A1 (en) 1995-09-29
DE69526467D1 (en) 2002-05-29
FI951357A0 (en) 1995-03-22
ES2176296T3 (en) 2002-12-01
NO951110D0 (en) 1995-03-23

Similar Documents

Publication Publication Date Title
ZA952418B (en) Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administration
AU7534087A (en) Sustained release pharmaceutical compositions in oral dosage form
AU8019991A (en) Programmed release oral solid pharmaceutical dosage form
IL89868A (en) Pharmaceutical compositions for oral administration, based on diphosphonic acid derivatives
EP0873749A4 (en) Jellied medicinal composition for oral administration
IL89702A0 (en) Water soluble ibuprofen compositions,processes for the preparation thereof and pharmaceutical compositions containing the same
HU0200688D0 (en) Pharmaceutical formulations with improved release containing solid salts of racemic thioctic acid
NO20000284D0 (en) Tannic acid polymer compositions for controlled release of pharmaceutical agents, especially in the oral cavity
HU9303364D0 (en) Compositions containing calcium, microelements, vitamine d and other medicinal components
BG106927A (en) Matrix tablet for prolonged release of trimetazidine after oral administration
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
ZA973495B (en) Matrix tablet allowing the prolonged release of the sodium salt of tianeptine after administration by the oral route.
NL194966B (en) 3 (2H) -pyridazinone derivatives and process for their preparation; pharmaceutical composition.
NZ234211A (en) Recompressed sustained release oral pharmaceutical composition containing water sensitive pharmaceutical agents, cellulose polymer and a lubricant
AU544975B2 (en) Oxazole derivatives
AU570446B2 (en) Dipyridamole controlled release compositon
AU1448692A (en) Gallic acid derivative, and pharmaceutical compositions containing it
HU9501654D0 (en) Tablet, capsule, or granule comprising desogestrel
GB2251620B (en) (S)-11-Hydroxy-10-methylaporphine, its physiologically acceptable salts and pharmaceutical compositions thereof
ZA914724B (en) Programmed release oral solid pharmaceutical dosage form
IE900393L (en) Pharmaceutical compositions for oral administration
UA10914C2 (en) Composition for preventing and treating avitaminosis in cattle and fowl
SG50537A1 (en) Phosphate-binding polymers for oral administration